News
-
Global MedAdvisor
Friday | Feb 1 2019LISTED medication adherence firm MedAdvisor is gearing up for international growth, with an ASX update yesterday confirming it had aligned its information security compliance systems to address US Health Insurance Probity and Accountability Act regulations.
-
Location rule “win”
Friday | Feb 1 2019MELBOURNE pharmacist Dominic Stambe has successfully challenged a decision by Health Minister Greg Hunt which allowed the opening of a pharmacy in a medical centre a few hundred metres from Stambe's two outlets.
-
FDA generic push
Friday | Feb 1 2019THE FDA has prioritised approvals for generic and biosimilar drugs to increase competition and is highlighting its success in the face of tighter US national budgets.
-
Dispensary Corner
Friday | Feb 1 2019
01 Feb 19A pop-up hamburger restaurant in Melbourne is attracting worldwide attention because of its links to Colombian drug lord Pablo Escobar.
-
-
Meds issues costing $1.4b
Thursday | Jan 31 2019THE annual cost of medication-related problems in Australia has been calculated at a whopping $1.4 billion - or about 15% of total PBS expenditure - according to a new report released by the Pharmaceutical Society of Australia.
-
Medlab seals Priceline deal
Thursday | Jan 31 2019LISTED medical life sciences firm Medlab Clinical has announced a new agreement with Australian Pharmaceutical Industries (API), which will stock Medlab's core nutraceutical range across its Priceline Pharmacy network.
-
Cannabis cookies fail
Thursday | Jan 31 2019CALIFORNIAN natural medicine physician William Eidelman is fighting to retain his licence after he prescribed cannabis cookies to a four-year-old boy.
-
Deprescribing hurdles
Thursday | Jan 31 2019POLYPHARMACY is increasing among older Australians, raising their risk of experiencing medication-related harm, according to Wollongong University researchers who identified factors affecting the process of deprescribing by GPs.
-
Reviewing antibiotics
Thursday | Jan 31 2019UK Community pharmacists will be called upon by the British Government to play an active role reviewing the dose and duration of antimicrobial prescriptions, as part of the country's plans to battle antimicrobial resistance.
